Skip to main content

Table 5 Characteristics of those responding "YES" to Q3 "shortness of breath", Q5 "asthma", or Q6 "treatment of asthma", according to the ECRHS main questionnaire (n = 146)

From: Population prevalence of asthma and its determinants based on European Community Respiratory Health Survey in the United Arab Emirates

  male
(n = 84)
female
(n = 62)
ALL
n = 146
p
Age in years, mean (SD) 30.8 (16.7) 33.9 (16.2) 32.6 (16.4) 0.263
Age band, n (%)     0.711
   • 19 yr or less 22 (26.2%) 17 (24.4%) 39 (26.7%)  
   • 20 to 44 yr 38 (45.2%) 31 (50.0%) 69 (47.3%)  
   • 45 yr or more 24 (28.6%) 14 (22.6%) 38 (26.0%)  
ECRHS screening questionnaire symptoms within the last 12 months, n (%)     
Wheezing/whistling 59 (70.2%) 49 (76.6%) 108 (73.0%) 0.457
   Wheezing with breathlessness 53 (63.1%) 45 (70.3%) 98 (66.2%) 0.649
   Wheezzing without a cold 52 (61.9%) 34 (53.1%) 86 (58.1%) 0.037*
Woken up with chest tightness 56 (66.7%) 38 (59.4%) 94 (63.5%) 0.392
Woken up by shortness of breath 67 (79.8%) 44 (68.8%) 111 (75.0%) 0.131
Woken up by an attack of coughing 54 (64.3%) 44 (68.5%) 98 (66.2%) 0.603
Attack of asthma 52 (61.9%) 47 (73.4%) 99 (66.9%) 0.161
Currently taking asthma medications 56 (66.7%) 42 (65.6%) 98 (66.2%) 1.000
Nasal allergies (including hay fever) 29 (34.5%) 27 (42.2%) 56 (37.8%) 0.394
  1. "*" Significant p-value